HEPA-MERZ

This brand name is authorized in Austria, Brazil, Croatia, Ecuador, Hong Kong SAR China, Lithuania, Mexico, Poland, Romania, Singapore, Turkey, UK.

Active ingredients

The drug HEPA-MERZ contains one active pharmaceutical ingredient (API):

1	2,5-Diaminopentanoate UNII JA08T3B97O - ORNITHINE ASPARTATE
	Read more about 2,5-Diaminopentanoate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HEPA-MERZ Concentrate for solution for infusion	MPI, EU: SmPC	Marketing Authorisation Holder

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A05BA	Liver therapy	A Alimentary tract and metabolism → A05 Bile and liver therapy → A05B Liver therapy, lipotropics
Discover more medicines within A05BA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	504109201153319, 504109202117316
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	02315-MAC-12-02, 29297-07-10
GB	Medicines & Healthcare Products Regulatory Agency	239661, 239662, 239663, 349515
HK	Department of Health Drug Office	25077, 26079
HR	Agencija za lijekove i medicinske proizvode	HR-H-362690583, HR-H-407623810
LT	Valstybinė vaistų kontrolės tarnyba	1021784, 1021785, 1085613, 1086590, 1087837, 1090317, 1090988
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	243M2000
PL	Rejestru Produktów Leczniczych	100028490, 100085625, 100294040, 100297630, 100333075, 100339563, 100393717, 100456227, 100462853, 100466777
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W01530001, W01530002, W01530003, W01531001
SG	Health Sciences Authority	15578P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699708200502, 8699708200519, 8699708760402, 8699708760457